Thrombosis And Hemostasis Biomarkers Market Latest Innovations And Challenges By 2030
Thrombosis And Hemostasis Biomarkers Industry The global thrombosis and hemostasis biomarkers market size is expected to reach USD 7.92 billion by 2030, expanding at a CAGR of 5.90% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rapid growth of the market is attributable to factors such as the increasing prevalence of chronic diseases such as pancreatic cancer, the rise in the geriatric population, the growing demand for personalized medicines, and advancements in technology. The thrombosis & hemostasis biomarkers industry has grown significantly in recent years, with changes in adoption patterns and the introduction of novel technologies. The increasing trend of adopting POC analyzers in the market is creating traction for small-sized analyzers. Increasing research on mini- and microdevices is anticipated to continue over the coming years. For instance, in June 2022, Dr. Arnold Lining Ju announced the development of a microdevice th...